返回 
加入收藏
肠外营养精细化用药规则设置及效果评价
x
请在关注微信后，向客服人员索取文件
| 篇名： | 肠外营养精细化用药规则设置及效果评价 |
| TITLE： | Fine setting and effect evaluation of parenteral nutrition refined medication rules |
| 摘要： | 目的 构建肠外营养（PN）精细化用药规则并评价其效果。方法基于药品说明书及相关指南、专家共识，构建PN精细化用药规则。通过合理用药监测系统（PASS）前置审核系统收集2024年1－12月（简称“干预后”）我院住院患者的PN医嘱信息，分析干预后的医嘱审核情况；通过医嘱点评系统收集2023年1－12月和2024年1－12月我院住院患者的PN医嘱信息，评价医嘱点评系统的PN医嘱点评合理率。结果所建PN精细化用药规则包括系统模块规则（营养物质、药物配伍、PN浓度和渗透压）和自定义审核规则（超适应证、药物配伍、其他用药条件）。截至2024年12月，PASS前置审核系统共建立PN系统模块规则55条、自定义审核规则47条，共计102条。干预后，与2024年第1季度比较，第4季度的药师审核和干预的PN任务数均减少，药师干预率降低，药师干预后医生修改率升高。PN系统模块规则下的不合理医嘱类型主要为PN浓度和渗透压不合理；自定义审核规则下的主要不合理医嘱类型为超适应证（氨基酸适应证）和药物配伍不合理。2024年，假阳性任务数、假阳性率均呈先升高后降低的趋势，人工点评不合理医嘱和假阴性率均呈下降趋势。2024年，经人工采用PN精细化用药规则进行PN医嘱点评后的总合理率显著高于2023年（P＜0.01）。结论我院成功构建了PN精细化用药规则，其能够降低PN用药风险、提高PN医嘱的合理率。 |
| ABSTRACT： | OBJECTIVE To establish refined medication rules for parenteral nutrition （PN） and evaluate its effectiveness. METHODS Refined medication rules for PN were constructed based on drug instructions， relevant guidelines， and expert consensus. Through the pre-approval review system of prescription automatic screening system （PASS）， PN prescription information for inpatients from January to December 2024 （referred to as “post-intervention”） was collected to analyze the post- intervention prescription review status. PN prescription information for inpatients at our hospital from January to December 2023 and January to December 2024 was collected through the medical order review system to evaluate the rationality rates of PN prescriptions. RESULTS The established refined medication rules for PN included system module rules （including nutrients， drug compatibility， PN concentration and osmotic pressure） and custom review rules （covering off-label drug use， drug compatibility， and other drug use conditions）. As of December 2024， the PASS pre-approval review system had established a total of 102 rules， comprising 55 system module rules and 47 custom review rules for PN. After intervention， when comparing with the first quarter of 2024， the number of PN reviewed and intervened by pharmacists decreased， the pharmacist intervention rate dropped， while the rate of physician modifications following pharmacist intervention increased in the fourth quarter. The primary types of irrational prescriptions identified by the system module rules were irrational PN concentration and osmotic pressure. The primary types of irrational prescriptions identified by the custom review rules were off-label drug use （specifically indications for amino acids） and irrational drug incompatibility. In 2024， the number of false-positive tasks and the false-positive rate initially increased and then decreased， while both the number of irrational prescriptions identified through manual review and the false-negative rate showed a declining trend. In 2024， the overall rationality rate after manual review PN refined medication rules for PN medical order review system significantly increased compared to that in 2023 （P＜0.01）. CONCLUSIONS The refined medication rules for PN in our hospital were established successfully， which can reduce the PN-induced risks and significantly improve the rationality of PN prescriptions. |
| 期刊： | 2025年第36卷第20期 |
| 作者： | 陈雨；顾婕；丁兰萍；马祝悦；袁红宇 |
| AUTHORS： | CHEN Yu，GU Jie，DING Lanping，MA Zhuyue，YUAN Hongyu |
| 关键字： | 精细化用药规则；肠外营养；处方前置审核；合理用药 |
| KEYWORDS： | refined medication rules； parenteral nutrition； |
| 阅读数： | 8 次 |
| 本月下载数： | 0 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
